江远投资张江：在大趋势下发掘“非共识”，寻找第一或唯一丨创投贺新春

Core Viewpoint - The article emphasizes the need for emerging VC firms to continuously identify value and create incremental growth amidst paradigm shifts in the market, particularly focusing on healthcare and technology sectors in 2025 [3]. Group 1: Investment Strategy - Jiangyuan Investment executed nearly 40 investments in 2025, with almost 60% of new projects in Series A or earlier stages, focusing on biomedicine, AI applications, and advanced manufacturing [3]. - The essence of VC is to find heterogeneity beyond the average, discovering potential in chaos and creating certainty in uncertain environments [5]. - Jiangyuan Investment prioritizes "not doing something" over "doing something," emphasizing the importance of focus and deep understanding to support entrepreneurs effectively [5]. Group 2: Global Expansion - With the approval of asset management and securities consulting licenses in Hong Kong and the establishment of a UK office, Jiangyuan's global capabilities have been enhanced, transforming China's advantages into global business opportunities [5]. - The firm aims to connect founders with strong motivation, clear vision, and rapid execution to the global innovation ecosystem, promoting differentiated value for Chinese innovation on the world stage [6]. Group 3: Entrepreneurial Support - Jiangyuan Investment seeks to resonate with outstanding entrepreneurs, aiming to be their earliest or most significant partner [4]. - The company supports entrepreneurs in refining their business models through real-world scenarios, solidifying their competitive advantages [5].